New ANDA Cases

Winter 2015

GENERICally Speaking
Case Name Date Filed Judge Drug Patent No(s).
Altergon SA v. Actavis Labs. UT, Inc., 15-0883 (D. Del.) Oct. 1, 2015 Hon. Richard G. Andrews Flector® (diclofenac epolamine patch) 5,607,690
Alcon Pharms. Ltd. v. Par Pharm., Inc., 15-7240 (D.N.J.) Oct. 1, 2015 Hon. Peter G. Sheridan Ciprodex® (ciprofloxacin / dexamethasone otic suspension)
6,284,804
6,359,016
Amerigen Pharms. Ltd. v. Shire LLC, IPR2015-02009 (PTAB) Oct. 1, 2015 N/A Adderall XR® (amphetamine aspartate / amphetamine sulfate / dextroamphetamine saccharate / dextroamphetamine sulfate extended-release capsules) RE42,096
Steadymed Ltd. v. United Therapeutics Corp., IPR2016-00006 (PTAB) Oct. 2, 2015 N/A
Remodulin® (treprostinil for injection)
Tyvaso® (treprostinil solution)
Orenitram® (treprostinil diolamine extended-release tablets)
8,497,393
Actavis Labs. UT, Inc. v. Par Pharm., Inc., 15-0886 (D. Del.) Oct. 2, 2015 Hon. Leonard P. Stark Gelnique® (oxybutynin chloride gel)
7,029,694
7,179,483
8,241,662
8,920,392
AbbVie Inc. v. Hetero USA Inc., 15-0889 (D. Del.) Oct. 2, 2015 Hon. Richard G. Andrews Kaletra® (lopinavir / ritonavir tablets)
6,037,157
6,703,403
7,148,359
7,364,752
8,025,899
8,268,349
8,399,015
8,309,613
8,377,952
8,470,347
8,691,878
Lupin Ltd. v. Daiichi Sankyo Co., Ltd., IPR2015-01881 (PTAB) Oct. 5, 2015 N/A Effient® (prasugrel hydrochloride tablets) 8,569,325
Lupin Ltd. v. Daiichi Sankyo Co., Ltd., IPR2015-01882 (PTAB) Oct. 5, 2015 N/A Effient® (prasugrel hydrochloride tablets) 8,404,703
Par Pharm., Inc. v. Jazz Pharms., Inc., IPR2016-00002 (PTAB) Oct. 6, 2015 N/A Xyrem® (sodium oxybate oral solution) 8,772,306
Ranbaxy Inc. v. Jazz Pharms., Inc., IPR2016-00024 (PTAB) Oct. 7, 2015 N/A Xyrem® (sodium oxybate oral solution) 8,772,306
Merck & CIE v. Lupin Ltd., 15-0899 (D. Del.) Oct. 8, 2015 Hon. Richard G. Andrews Beyaz® (drospirenone / 17α-ethinylestradiol / levomefolate calcium tablets) 6,441,168
Salix Pharms., Inc. v. Taro Pharms. USA, Inc., 15-0900 (D. Del.) Oct. 8, 2015 Hon. Sue L. Robinson Moviprep® (ascorbic acid / polyethylene glycol 3350 / potassium chloride / sodium ascorbate / sodium chloride / sodium sulfate oral solution)
7,169,381
7,658,914
Helsinn Healthcare S.A. v. Fresenius Kabi USA, LLC, 15-7378 (D.N.J.) Oct. 8, 2015 Hon. Mary L. Cooper Aloxi® (palonosetron hydrochloride for injection)
7,947,724
8,518,981
8,598,218
9,066,980
9,125,905
Bayer Intellectual Property GmbH v. Aurobindo Pharma Ltd., 15-0902 (D. Del.) Oct. 9, 2015 Hon. Sue L. Robinson Xarelto® (rivaroxaban tablets)
7,157,456
7,585,860
7,592,339
Forest Labs., LLC v. Accord Healthcare, Inc., 15-0903 (D. Del.) Oct. 9, 2015 Hon. Leonard P. Stark Namenda® XR (memantine hydrochloride extended-release tablets)
8,039,009
8,168,209
8,173,708
8,283,379
8,329,752
8,362,085
8,598,233
Unimed Pharms., LLC v. Lupin Atlantis Holdings SA, 15-0904 (D. Del.) Oct. 9, 2015 Hon. Richard G. Andrews AndroGel® (testosterone gel)
6,503,894
8,466,136
8,466,137
8,466,138
8,486,925
8,729,057
8,741,881
8,754,070
8,759,329
9,125,816
9,132,089
Novartis Pharms. Corp. v. Roxane Labs., Inc., 15-0908 (D. Del.) Oct. 9, 2015 Hon. Leonard P. Stark Gleevec® (imatinib mesylate tablets)
6,894,051
RE43,932
AstraZeneca AB v. Teva Pharms. USA, Inc., 15-0909 (D. Del.) Oct. 9, 2015 Hon. Gregory M. Sleet Kombiglyze™ XR (saxagliptin hydrochloride / metformin hydrochloride extended-release tablets) 8,628,799
AstraZeneca AB v. Zydus Pharms. (USA) Inc., 15-7415 (D.N.J.) Oct. 9, 2015 Hon. Mary L. Cooper Nexium® (esomeprazole magnesium delayed-release tablets)
6,369,085
7,411,070
8,466,175
Salix Pharms., Inc. v. Taro Pharms. USA, Inc., 15-7980 (S.D.N.Y.) Oct. 9, 2015 Hon. Vernon S. Broderick Moviprep® (ascorbic acid / polyethylene glycol 3350 / potassium chloride / sodium ascorbate / sodium chloride / sodium sulfate oral solution)
7,169,381
7,658,914
Flamel Ireland, Ltd. v. Mylan Pharms. Inc., 15-0178 (N.D.W.V.) Oct. 9, 2015 Hon. Irene M. Keeley Coreg CR® (carvedilol phosphate extended-release capsules) 8,101,209
Agila Specialties Inc. f/k/a Strides Inc. v. Cephalon, Inc., IPR2016-00026 (PTAB) Oct. 9, 2015 N/A Treanda® (bendamustine hydrochloride for infusion) 8,791,270
Helsinn Healthcare S.A. v. Fresenius Kabi USA, LLC, 15-0918 (D. Del.) Oct. 13, 2015 Hon. Gregory M. Sleet Aloxi® (palonosetron hydrochloride for injection)
7,947,724
8,518,981
8,598,218
9,066,980
9,125,905
Vanda Pharms. Inc. v. Roxane Labs., Inc., 15-0919 (D. Del.) Oct. 13, 2015 Hon. Gregory M. Sleet Fanapt® (iloperidone tablets) 9,138,432
Vanda Pharms. Inc. v. Taro Pharms. USA, Inc., 15-0920 (D. Del.) Oct. 13, 2015 Hon. Gregory M. Sleet Fanapt® (iloperidone tablets)
8,586,610
9,138,432
Vanda Pharms. Inc. v. Inventia Healthcare Pvt. Ltd., 15-0921 (D. Del.) Oct. 13, 2015 Hon. Gregory M. Sleet Fanapt® (iloperidone tablets) 9,138,432
Vanda Pharms. Inc. v. Apotex Inc., 15-0922 (D. Del.) Oct. 13, 2015 Hon. Gregory M. Sleet Fanapt® (iloperidone tablets)
8,586,610
9,138,432
Boehringer Ingelheim Pharma GmbH & Co. KG v. Sandoz Inc., 15-7461 (D.N.J.) Oct. 13, 2015 Hon. Noel L. Hillman Aggrenox® (dipyridamole / acetylsalicylic acid extended-release capsules) 6,015,577
Novartis Pharms. Corp. v. Roxane Labs., Inc., 15-2905 (S.D. Ohio) Oct. 13, 2015 Hon. Edmund A Sargus Gleevec® (imatinib mesylate tablets)
6,894,051
RE43,932
AstraZeneca Pharms. LP v. Mylan Pharms. Inc., 15-0183 (N.D.W.V.) Oct. 15, 2015 Hon. Irene M. Keeley Faslodex® (fulvestrant injection)
6,774,122
7,456,160
8,329,680
8,466,139
Neptune Generics, LLC v. AstraZeneca PLC., IPR2016-00049 (PTAB) Oct. 15, 2015 N/A Movantik® (naloxegol oxalate tablets) 7,786,133
Purdue Pharma L.P. v. Alvogen Pine Brook, Inc., 15-0940 (D. Del.) Oct. 16, 2015 Hon. Gregory M. Sleet Hysingla® ER (hydrocodone bitartrate extended-release tablets)
9,084,816
9,095,614
9,095,615
Fresenius Kabi USA, LLC v. Mylan Labs. Ltd., 15-0942 (D. Del.) Oct. 19, 2015 Hon. Leonard P. Stark Naropin® (ropivacaine hydrochloride for injection)
7,828,787
7,857,802
8,118,802
8,162,915
Jazz Pharms., Inc. v. Par Pharm., Inc., 15-7580 (D.N.J.) Oct. 19, 2015 Hon. Esther Salas Xyrem® (sodium oxybate oral solution) 9,050,302
Otsuka Pharm. Co., Ltd. v. Aurobindo Pharma Ltd., 15-7584 (D.N.J.) Oct. 19, 2015 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,089,567
Horizon Therapeutics, Inc. v. Lupin Ltd., 15-7624 (D.N.J.) Oct. 19, 2015 Hon. Robert B. Kugler Ravicti® (glycerol phenylbutyrate oral liquid)
8,404,215
8,642,012
9,095,559
Fresenius Kabi USA, LLC v. Mylan Labs. Ltd., 15-0185 (N.D.W.V.) Oct. 19, 2015 Hon. Irene M. Keeley Naropin® (ropivacaine hydrochloride for injection)
7,828,787
7,857,802
8,118,802
8,162,915
Alcon Pharms. Ltd. v. Akorn, Inc., 15-0948 (D. Del.) Oct. 21, 2015 Hon. Sue L. Robinson Vigamox® (moxifloxacin hydrochloride ophthalmic solution)
6,716,830
7,671,070
Takeda Pharm. Co. Ltd. v. Aurobindo Pharma Ltd., 15-7635 (D.N.J.) Oct. 21, 2015 Hon. Mary L. Cooper Prevacid® SoluTab™ (lansoprazole delayed-release orally disintegrating tablets)
6,328,994
7,431,942
7,875,292
7,399,485
Pfizer Inc. v. Mylan Inc., 15-0960 (D. Del.) Oct. 22, 2015 Hon. Sue L. Robinson Tygacil® (tigecycline injectable IV infusion)
7,879,828
8,372,995
8,975,242
Unimed Pharms., LLC v. Amneal Pharms., LLC, 15-0964 (D. Del.) Oct. 23, 2015 Hon. Richard G. Andrews AndroGel® (testosterone gel)
6,503,894
8,729,057
8,741,881
8,754,070
8,759,329
9,125,816
9,132,089
Forest Labs., LLC v. Amerigen Pharms., Inc., 15-0966 (D. Del.) Oct. 23, 2015 Hon. Leonard P. Stark Namzaric® (memantine hydrochloride / donepezil hydrochloride extended-release capsules)
8,039,009
8,058,291
8,168,209
8,173,708
8,283,379
8,293,794
8,329,752
8,338,485
8,338,486
8,362,085
8,580,858
8,598,233
Tris Pharma, Inc. v. Actavis Labs. FL, Inc., 15-0969 (D. Del.) Oct. 23, 2015 Hon. Gregory M. Sleet Quillivant XR® (methylphenidate hydrochloride extended-release oral suspension) 9,040,083
Takeda Pharm. Co. Ltd. v. Aurobindo Pharma Ltd., 15-9398 (N.D. Ill.) Oct. 23, 2015 Hon. Charles P. Kocoras Prevacid® SoluTab™ (lansoprazole delayed-release orally disintegrating tablets)
6,328,994
7,431,942
7,875,292
7,399,485
Tris Pharma, Inc. v. Actavis Labs. FL, Inc., 15-7684 (D.N.J.) Oct. 23, 2015 Hon. Claire C. Cecchi Quillivant XR® (methylphenidate hydrochloride extended-release oral suspension) 9,040,083
Mallinckrodt LLC v. Par Pharm. Inc., 15-7694 (D.N.J.) Oct. 23, 2015 Hon. Katharine S. Hayden Xartemis XR® (oxycodone hydrochloride / acetaminophen extended-release tablets)
6,488,962
8,597,681
8,658,631
8,741,885
8,980,319
8,992,975
7,976,870
8,668,929
8,372,432
8,377,453
8,394,408
9,050,335
Pfizer Inc. v. Mylan Inc., 15-0188 (N.D.W.V.) Oct. 23, 2015 Hon. Irene M. Keeley Tygacil® (tigecycline injectable IV infusion)
7,879,828
8,372,995
8,975,242
Novartis AG v. Apotex Inc., 15-0975 (D. Del.) Oct. 26, 2015 Hon. Leonard P. Stark Gilenya® (fingolimod capsules) 5,604,229
Par Pharm., Inc. v. Novartis AG, IPR2016-00074 (PTAB) Oct. 26, 2015 N/A Afinitor® (everolimus tablets) 7,741,338
Par Pharm., Inc. v. Novartis AG, IPR2016-00075 (PTAB) Oct. 26, 2015 N/A Afinitor® (everolimus tablets) 7,297,703
Par Pharm., Inc. v. Novartis AG, IPR2016-00078 (PTAB) Oct. 26, 2015 N/A Zortress® (everolimus tablets) 6,455,518
Par Pharm., Inc. v. Novartis AG, IPR2016-00084 (PTAB) Oct. 26, 2015 N/A Zortress® (everolimus tablets) 5,665,772
Complex Innovations, LLC v. Amgen Inc., IPR2016-00085 (PTAB) Oct. 26, 2015 N/A Sensipar® (cinacalcet hydrochloride tablets) 7,829,595
Noven Pharms., Inc. v. Mylan Technologies Inc., 15-0979 (D. Del.) Oct. 27, 2015 Hon. Leonard P. Stark Daytrana® (methylphenidate transdermal system)
6,210,705
6,348,211
8,632,802
9,034,370
Horizon Pharma Ireland Ltd. v. Actavis Labs. UT, Inc., 15-7742 (D.N.J.) Oct. 27, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution)
9,168,304
9,168,305
Horizon Pharma Ireland Ltd. v. Amneal Pharms. LLC, 15-7743 (D.N.J.) Oct. 27, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution)
9,168,304
9,168,305
Horizon Pharma Ireland Ltd. v. IGI Labs., Inc., 15-7744 (D.N.J.) Oct. 27, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution)
9,168,304
9,168,305
Horizon Pharma Ireland Ltd. v. Lupin Ltd., 15-7745 (D.N.J.) Oct. 27, 2015 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution)
9,168,304
9,168,305
Novartis Pharms. Corp. v. Amneal Pharms. LLC, 15-0986 (D. Del.) Oct. 28, 2015 Hon. Leonard P. Stark Gleevec® (imatinib mesylate tablets)
6,894,051
RE43,932
Novartis Pharms. Corp. v. Natco Pharma Ltd., 15-0987 (D. Del.) Oct. 28, 2015 Hon. Leonard P. Stark Gleevec® (imatinib mesylate tablets)
6,894,051
RE43,932
Novartis AG v. Apotex Inc., 15-62273 (S.D. Fla.) Oct. 28, 2015 Hon. Beth Bloom Gilenya® (fingolimod capsules) 5,604,229
Fresenius Kabi USA, LLC v. Cephalon, Inc., IPR2016-00098 (PTAB) Oct. 28, 2015 N/A Treanda® (bendamustine hydrochloride for infusion) 8,791,270
Novartis Pharms. Corp. v. Natco Pharma Ltd., 15-8534 (S.D.N.Y.) Oct. 29, 2015 Hon. Andrew L. Carter, Jr, Gleevec® (imatinib mesylate tablets)
6,894,051
RE43,932
Noven Pharms., Inc. v. Mylan Technologies Inc., 15-0194 (N.D.W.V.) Oct. 29, 2015 Hon. Irene M. Keeley Daytrana® (methylphenidate transdermal system)
6,210,705
6,348,211
8,632,802
9,034,370
Orexo AB v. Actavis Elizabeth LLC, 15-0996 (D. Del.) Oct. 30, 2015 Hon. Sue L. Robinson Zubsolv® (buprenorphine hydrochloride / naloxone hydrochloride tablets)
8,454,996
8,940,330
AstraZeneca LP v. Mylan Inc., 15-0999 (D. Del.) Oct. 30, 2015 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets)
6,251,910
6,525,060
7,250,419
7,265,124
8,425,934
AstraZeneca LP v. Sigmapharm Labs., LLC, 15-1000 (D. Del.) Oct. 30, 2015 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets)
6,251,910
6,525,060
7,250,419
7,265,124
8,425,934
AstraZeneca LP v. InvaGen Pharms. Inc., 15-1001 (D. Del.) Oct. 30, 2015 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets)
6,251,910
6,525,060
7,250,419
7,265,124
8,425,934
AstraZeneca LP v. Watson Labs., Inc., 15-1002 (D. Del.) Oct. 30, 2015 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets) 8,425,934
AstraZeneca LP v. Alembic Pharms. Ltd., 15-1003 (D. Del.) Oct. 30, 2015 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets) 8,425,934
Otsuka Pharm. Co., Ltd. v. Zydus Pharms. USA Inc., 15-7802 (D.N.J.) Oct. 30, 2015 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,089,567
Otsuka Pharm. Co., Ltd. v. Amneal Pharms. LLC, 15-7803 (D.N.J.) Oct. 30, 2015 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,089,567
AstraZeneca LP v. InvaGen Pharms. Inc, 15-6282 (E.D.N.Y.) Nov. 2, 2015 Hon. Kiyo A. Matsumoto Brilinta® (ticagrelor tablets)
6,251,910
6,525,060
7,250,419
7,265,124
8,425,934
Innopharma Licensing, Inc. v. Senju Pharm. Co., Ltd., IPR2016-00089 (PTAB) Nov. 2, 2015 N/A Prolensa® (bromfenac sodium ophthalmic solution) 8,754,131
Innopharma Licensing, Inc. v. Senju Pharm. Co., Ltd., IPR2016-00090 (PTAB) Nov. 2, 2015 N/A Prolensa® (bromfenac sodium ophthalmic solution) 8,871,813
Innopharma Licensing, Inc. v. Senju Pharm. Co., Ltd., IPR2016-00091 (PTAB) Nov. 2, 2015 N/A Prolensa® (bromfenac sodium ophthalmic solution) 8,927,606
Fresenius Kabi USA, LLC v. Cephalon, Inc., IPR2016-00111 (PTAB) Nov. 2, 2015 N/A Treanda® (bendamustine hydrochloride for infusion) 8,895,756
AstraZeneca LP v. Sigmapharm Labs., LLC, 15-5948 (E.D. Pa.) Nov. 2, 2015 Hon. Gerald A. McHugh Brilinta® (ticagrelor tablets)
6,251,910
6,525,060
7,250,419
7,265,124
8,425,934
AstraZeneca LP v. Mylan In., LLC, 15-0202 (N.D.W.V.) Nov. 2, 2015 Hon. Irene M. Keeley Brilinta® (ticagrelor tablets)
6,251,910
6,525,060
7,250,419
7,265,124
8,425,934
Purdue Pharma L.P. v. Actavis Labs. FL, Inc., 15-1008 (D. Del.) Nov. 3, 2015 Hon. Gregory M. Sleet Hysingla® ER (hydrocodone bitartrate extended-release tablets)
9,056,052
9,060,940
9,084,816
9,095,614
Boehringer Ingelheim Pharma Gmbh & Co. KG v. Apotex Corp., 15-7880 (D.N.J.) Nov. 3, 2015 Hon. Mary L. Cooper Pradaxa® ER (dabigatran etexilate mesylate capsules) 6,087,380
AstraZeneca Pharms. LP v. Teva Pharms. USA, Inc., 15-7889 (D.N.J.) Nov. 3, 2015 Hon. Renee Marie Bumb Faslodex® (fulvestrant injection)
6,774,122
7,456,160
8,329,680
8,466,139
AstraZeneca LP v. Sandoz Inc., 15-1012 (D. Del.) Nov. 4, 2015 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets) 8,425,934
AstraZeneca LP v. Micro Labs Ltd., 15-1013 (D. Del.) Nov. 4, 2015 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets) 8,425,934
Indivior Inc. v. Mylan Technologies Inc., 15-1016 (D. Del.) Nov. 4, 2015 Hon. Richard G. Andrews Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride sublingual film)
8,475,832
8,017,150
8,603,514
Warner Chilcott Co., LLC v. Mylan Pharms. Inc., 15-7882 (D.N.J.) Nov. 4, 2015 Hon. Mary L. Cooper Minastrin® 24 Fe (ethinyl estradiol / norethindrone acetate / ferrous fumarate tablets) 6,667,050
Novartis Pharms. Corp. v. Amneal Pharms. LLC, 15-1025 (D. Del.) Nov. 5, 2015 Hon. Richard G. Andrews Exelon® Patch (rivastigmine transdermal system or extended release film)
6,316,023
6,335,031
Novartis Pharms. Corp. v. Dr. Reddy’s Labs, Ltd., 15-1026 (D. Del.) Nov. 5, 2015 Hon. Richard G. Andrews Exelon® Patch (rivastigmine transdermal system or extended release film)
6,316,023
6,335,031
Takeda Gmbh v. Micro Labs USA, Inc., 15-7921 (D.N.J.) Nov. 5, 2015 Hon. Freda L. Wolfson Daliresp® (roflumilast tablets) 5,712,298
Dow Pharm. Sciences, Inc. v. Tolmar, Inc., 15-7971 (D.N.J.) Nov. 5, 2015 Hon. Stanley R. Chesler Acanya® (clindamycin phosphate / benzoyl peroxide gel)
8,288,434
8,663,699
Indivior Inc. v. Mylan Technologies Inc., 15-0209 (N.D.W.V.) Nov. 5, 2015 Hon. Irene M. Keeley Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride sublingual film)
8,475,832
8,017,150
8,603,514
Dow Pharm. Sciences, Inc. v. Tolmar, Inc., 15-1030 (D. Del.) Nov. 6, 2015 Hon. Gregory M. Sleet Acanya® (clindamycin phosphate / benzoyl peroxide gel)
8,288,434
8,663,699
Allergan Sales, LLC v. Aurobindo Pharma Ltd., 15-1032 (D. Del.) Nov. 6, 2015 Hon. Leonard P. Stark Acular LS® (ketorolac tromethamine ophthalmic solution)
8,008,338
8,207,215
8,377,982
8,541,463
8,648,107
8,906,950
8,946,281
Purdue Pharma L.P. v. Collegium Pharm., Inc., 15-13783 (D. Mass.) Nov. 6, 2015 Hon. F. Dennis Saylor, IV
OxyContin® (oxycodone extended-release tablets)
Xtampza ER™ (oxycodone extended-release capsules)
9,073,933
Novartis Pharms. Corp. v. Dr. Reddy’s Labs, Ltd., 15-7964 (D.N.J.) Nov. 6, 2015 Hon. Renee Marie Bumb Exelon® Patch (rivastigmine transdermal system or extended release film)
6,316,023
6,335,031
Allergan Sales, LLC v. Aurobindo Pharma Ltd., 15-1719 (E.D. Tex.) Nov. 6, 2015 Hon. Rodney Gilstrap Acular LS® (ketorolac tromethamine ophthalmic solution)
8,008,338
8,207,215
8,377,982
8,541,463
8,648,107
8,906,950
8,946,281
Warner Chilcott (US), LLC v. Mylan Pharms., Inc., 15-1740 (E.D. Tex.) Nov. 9, 2015 Hon. Rodney Gilstrap Delzicol® (mesalamine delayed-release capsules) 6,649,180
Shire Pharm. Development Inc. v. Lupin Ltd., 15-3437 (D. Md.) Nov. 10, 2015 Hon. George Jarrod Hazel Lialda® (mesalamine delayed-release tablets) 6,773,720
Dexcel Pharma Technologies Ltd. v. Apotex Corp., 15-8010 (D.N.J.) Nov. 10, 2015 Hon. Susan D. Wigenton Omeprazole delayed-release tablets
9,023,391
7,255,878
Dexcel Pharma Technologies Ltd. v. Sun Pharma Global FZE, 15-8017 (D.N.J.) Nov. 11, 2015 Hon. Susan D. Wigenton Omeprazole delayed-release tablets
9,023,391
7,255,878
Par Pharm., Inc. v. Breckenridge Pharm., Inc., 15-1039 (D. Del.) Nov. 11, 2015 Hon. Sue L. Robinson Megace® ES (megestrol acetate oral suspension)
9,101,540
9,101,549
9,107,827
AstraZeneca LP v. HEC Pharm Co., Ltd., 15-1041 (D. Del.) Nov. 12, 2015 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets)
7,265,124
8,425,934
AstraZeneca LP v. Hisun Pharm. (Hangzhou) Co., Ltd., 15-1042 (D. Del.) Nov. 12, 2015 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets) 8,425,934
Cephalon, Inc. v. Aurobindo Pharma Ltd., 15-1044 (D. Del.) Nov. 12, 2015 Hon. Gregory M. Sleet Nuvigil® (armodafinil tablets) 7,132,570
Shire Development LLC v. Apotex, Inc., 15-1045 (D. Del.) Nov. 12, 2015 Hon. Leonard P. Stark Fosrenol® (lanthanum carbonate tablets)
5,968,976
7,381,428
7,465,465
Dexcel Pharma Technologies Ltd. v. Dr. Reddy’s Labs., Ltd., 15-8042 (D.N.J.) Nov. 12, 2015 Hon. Susan D. Wigenton Omeprazole delayed-release tablets
9,023,391
7,255,878
Graybar Pharms., LLC v. Pozen, Inc., IPR2016-00191 (PTAB) Nov. 12, 2015 N/A Treximet® (naproxen sodium / sumatriptan succinate tablets) 7,332,183
Cosmo Technologies Ltd. v. Actavis Labs. FL, Inc., 15-1046 (D. Del.) Nov. 13, 2015 Hon. Leonard P. Stark Uceris® (budesonide tablets) 9,132,093
Cosmo Technologies Ltd. v. Alvogen Pine Brook, LLC, 15-1047 (D. Del.) Nov. 13, 2015 Hon. Leonard P. Stark Uceris® (budesonide tablets) 9,132,093
Cosmo Technologies Ltd. v. Lupin Ltd., 15-1048 (D. Del.) Nov. 13, 2015 Hon. Leonard P. Stark Uceris® (budesonide tablets) 9,132,093
Cosmo Technologies Ltd. v. Par Pharm., Inc., 15-1049 (D. Del.) Nov. 13, 2015 Hon. Leonard P. Stark Uceris® (budesonide tablets) 9,132,093
Novartis Pharms. Corp. v. Par Pharm., Inc., 15-1050 (D. Del.) Nov. 13, 2015 Hon. Richard G. Andrews Afinitor® (everolimus tablets) 8,436,010
Indivior Inc. v. Sandoz Inc., 15-1051 (D. Del.) Nov. 13, 2015 Hon. Richard G. Andrews Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride sublingual film)
8,475,832
8,017,150
8,603,514
AstraZeneca LP v. HEC Pharm Co., Ltd., 15-8082 (D.N.J..) Nov. 13, 2015 Hon. Peter G. Sheridan Brilinta® (ticagrelor tablets)
7,265,124
8,425,934
AstraZeneca LP v. Amneal Pharms. LLC, 15-1056 (D. Del.) Nov. 16, 2015 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets)
6,251,910
6,525,060
7,250,419
7,265,124
8,425,934
AstraZeneca LP v. Prinston Pharm. Inc., 15-1057 (D. Del.) Nov. 16, 2015 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets)
6,251,910
6,525,060
7,250,419
7,265,124
8,425,934
AstraZeneca LP v. Apotex Inc., 15-1058 (D. Del.) Nov. 16, 2015 Hon. Richard G. Andrews Brilinta® (ticagrelor tablets)
6,525,060
7,250,419
7,265,124
8,425,934
Merck, Sharp & Dohme Corp. v. Hetero USA Inc., 15-8099 (D.N.J.) Nov. 16, 2015 Hon. Claire C. Cecchi Sustiva® (efavirenz tablets)
6,639,071
6,939,964
Osi Pharms., LLC v. Breckenridge Pharm., Inc., 15-1063 (D. Del.) Nov. 17, 2015 Hon. Sue L. Robinson Tarceva® (erlotinib hydrochloride tablets)
RE41,065
6,900,221
Helsinn Healthcare S.A. v. Qilu Pharm. Co., Ltd., 15-8132 (D.N.J.) Nov. 17, 2015 Hon. Mary L. Cooper Aloxi® (palonosetron hydrochloride for injection)
7,947,724
8,729,094
9,066,980
9,173,942
Pfizer Inc. v. Dr. Reddy’s Labs., Ltd., 15-1067 (D. Del.) Nov. 18, 2015 Hon. Gregory M. Sleet Toviaz® (fesoterodine fumarate extended-release tablets)
6,858,650
7,384,980
7,855,230
7,985,772
8,338,478
Vanda Pharms. Inc. v. Lupin Ltd., 15-1073 (D. Del.) Nov. 19, 2015 Hon. Gregory M. Sleet Fanapt® (iloperidone tablets)
8,586,610
9,138,432
Cephalon, Inc. v. Fresenius Kabi USA, LLC, 15-1074 (D. Del.) Nov. 19, 2015 Hon. Sue L. Robinson Trisenox® (arsenic trioxide injection)
6,723,351
6,855,339
6,861,076
6,884,439
Valeant Pharms. Int’l, Inc. v. Mylan Pharms., Inc., 15-8180 (D.N.J.) Nov. 19, 2015 Hon. Stanley R. Chesler Relistor® (methylnaltrexone bromide injection)
8,247,425
8,420,663
8,552,025
8,822,490
Pfizer Inc. v. Dr. Reddy’s Labs., Ltd., 15-8226 (D.N.J.) Nov. 19, 2015 Hon. Renee Marie Bumb Toviaz® (fesoterodine fumarate extended-release tablets)
6,858,650
7,384,980
7,855,230
7,985,772
8,338,478
AstraZeneca AB v. Dr. Reddy’s Labs., Inc., 15-8267 (D.N.J.) Nov. 19, 2015 Hon. Mary L. Cooper Nexium 24HR® (esomeprazole magnesium delayed-release capsules)
6,369,085
7,411,070
Mylan Pharms. Inc. v. Baxter Int’l Inc., IPR2016-00217 (PTAB) Nov. 19, 2015 N/A Brevibloc® (esmolol hydrochloride injection) 6,310,094
Mylan Pharms. Inc. v. Baxter Int’l Inc., IPR2016-00218 (PTAB) Nov. 19, 2015 N/A Brevibloc® (esmolol hydrochloride injection) 6,528,540
Purdue Pharma L.P. v. Alvogen Pine Brook LLC, 15-1077 (D. Del.) Nov. 20, 2015 Hon. Sue L. Robinson Butrans® (buprenorphine transdermal system)
RE41,408
RE41,489
RE41,571
Shire LLC v. Abhai, LLC, 15- (D. Mass.) Nov. 20, 2015 Hon. William G. Young Adderall XR® (amphetamine aspartate / amphetamine sulfate / dextroamphetamine saccharate / dextroamphetamine sulfate extended-release capsules)
RE42,096
RE41,148
Forest Labs., LLC v. InvaGen Pharms. Inc., 15-1078 (D. Del.) Nov. 23, 2015 Hon. Gregory M. Sleet Viibryd® (vilazodone hydrochloride tablets)
7,834,020
8,193,195
8,236,804
8,673,921
Jazz Pharms., Inc. v. Sun Pharm. Indus. Ltd., 15-8229 (D.N.J.) Nov. 23, 2015 Hon. Esther Salas Xyrem® (sodium oxybate oral solution) 9,050,302
Argentum Pharms. LLC v. Research Corp. Technologies, Inc., IPR2016-00204 (PTAB) Nov. 23, 2015 N/A Vimpat® (lacosamide) RE38,551
Horizon Pharma, Inc. v. Actavis Labs. Fl., Inc. 15-8523 (D.N.J.) Nov. 24, 2015 Hon. Mary L. Cooper Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets)
6,926,907
8,557,285
Horizon Pharma, Inc. v. Actavis Labs. Fl., Inc. 15-8524 (D.N.J.) Nov. 24, 2015 Hon. Mary L. Cooper Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets)
8,852,636
8,858,996
8,865,190
Neptune Generics, LLC v. Eli Lilly & Co., IPR2016-00237 (PTAB) Nov. 24, 2015 N/A Alimta® (pemetrexed disodium injection) 7,772,209
Neptune Generics, LLC v. Eli Lilly & Co., IPR2016-00240 (PTAB) Nov. 24, 2015 N/A Alimta® (pemetrexed disodium injection) 7,772,209
J. Kyle Bass v. Alpex Pharma., IPR2016-00245 (PTAB) Nov. 24, 2015 N/A Suprenza® (phentermine hydrochloride tablets) 8,440,170
Symed Labs Ltd. v. Roxane Labs., Inc., 15-8304 (D.N.J.) Nov. 25, 2015 Hon. Claire C. Cecchi Form III Linezolid (linezolid oral suspension)
7,714,128
7,732,597
7,718,800
7,718,799
Otsuka Pharm. Co., Ltd. v. Alkem Labs. Ltd., 15-8305 (D.N.J.) Nov. 25, 2015 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets)
8,017,615
8,580,796
8,642,760
Symed Labs Ltd. v. Glenmark Pharms. Inc., USA, 15-8306 (D.N.J.) Nov. 25, 2015 Hon. Claire C. Cecchi Form III Linezolid (linezolid oral suspension)
7,714,128
7,732,597
Symed Labs Ltd. v. Amneal Pharms. LLC, 15-8307 (D.N.J.) Nov. 25, 2015 Hon. Claire C. Cecchi Form III Linezolid (linezolid oral suspension)
7,714,128
7,732,597
7,718,800
7,718,799
Supernus Pharms., Inc. v. Actavis Inc., 15-8342 (D.N.J.) Nov. 25, 2015 Hon. Renee Marie Bumb Oxtellar XR® (oxcarbazepine extended-release tablets) 9,119,791
J. Kyle Bass v. Fresenius Kabi USA, LLC, IPR2016-00254 (PTAB) Nov. 25, 2015 N/A Diprivan® (propofol injection) 8,476,010
Shire Orphan Therapies LLC v. Fresenius Kabi USA, LLC, 15-1102 (D. Del.) Nov. 30, 2015 Hon. Gregory M. Sleet Firazyr® (icatibant acetate) 5,648,333
Novartis Pharms. Corp. v. Shilpa Medicare Ltd., 15-1111 (D. Del.) Nov. 30, 2015 Hon. Leonard P. Stark Gleevec® (imatinib mesylate tablets)
6,894,051
RE43,932
Valeant Pharms. Int’l, Inc. v. Actavis LLC, 15-8353 (D.N.J.) Nov. 30, 2015 Hon. Stanley R. Chesler Relistor® (methylnaltrexone bromide injection)
8,247,425
8,420,663
8,552,025
8,822,490
Helsinn Healthcare S.A. v. Qilu Pharm. Co., Ltd., 15-6392 (E.D. Pa.) Dec. 1, 2015 Hon. Cynthia M. Rufe Aloxi® (palonosetron hydrochloride for injection)
7,947,724
8,729,094
9,066,980
9,173,942
Unimed Pharms., LLC v. Sandoz Inc., 15-1120 (D. Del.) Dec. 3, 2015 Hon. Richard G. Andrews AndroGel® (testosterone gel)
6,503,894
8,466,136
8,466,137
8,466,138
8,486,925
8,729,057
8,741,881
8,754,070
8,759,329
9,125,816
9,132,089
Teva Pharms. USA, Inc. v. RB Pharms. Ltd., IPR2016-00280 (PTAB) Dec. 3, 2015 N/A Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride sublingual film) 8,475,832
Teva Pharms. USA, Inc. v. MonSol Rx, LLC, IPR2016-00281 (PTAB) Dec. 3, 2015 N/A Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride sublingual film) 8,603,514
Teva Pharms. USA, Inc. v. MonoSol RX, LLC, IPR2016-00282 (PTAB) Dec. 3, 2015 N/A Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride sublingual film) 8,017,150
UCB, Inc. v. InvaGen Pharms., Inc., 15-6919 (E.D.N.Y.) Dec. 4, 2015 Hon. Kiyo A. Matsumoto Zyrtec-D® (cetirizine hydrochloride / pseudoephedrine hydrochloride tablets)
6,469,009
7,014,867
7,226,614
Galderma Labs., L.P. v. Teligent, Inc., 15-3876 (N.D. Tex.) Dec. 4, 2015 Hon. David C. Godbey Clobex® (clobetasol propionate topical solution) 6,106,848
Lupin Ltd. v. Horizon Therapeutics, Inc., IPR2016-00283 (PTAB) Dec. 4, 2015 N/A Ravicti® (glycerol phenylbutyrate oral liquid) 8,642,012
Lupin Ltd. v. Horizon Therapeutics, Inc., IPR2016-00284 (PTAB) Dec. 4, 2015 N/A Ravicti® (glycerol phenylbutyrate oral liquid) 8,404,215
Amerigen Pharms. Ltd. v. Janssen Oncology, Inc, IPR2016-00286 (PTAB) Dec. 4, 2015 N/A Zytiga® (abiraterone acetate tablets) 8,822,438
Takeda Gmbh v. Apotex Corp., 15-8492 (D.N.J.) Dec. 7, 2015 Hon. Freda L. Wolfson Daliresp® (roflumilast tablets) 5,712,298
AstraZeneca Pharms. LP v. Amneal Pharms. LLC, 15-1139 (D. Del.) Dec. 9, 2015 Hon. Gregory M. Sleet Byetta® (exenatide injection)
6,872,700
6,902,744
Unimed Pharms., LLC v. Dr. Reddy’s Labs., Ltd., 15-1142 (D. Del.) Dec. 10, 2015 Hon. Richard G. Andrews AndroGel® (testosterone gel)
6,503,894
8,466,136
8,466,137
8,466,138
8,486,925
8,729,057
8,741,881
8,754,070
8,759,329
9,125,816
9,132,089
Celgene Corp. v. Teva Pharms. USA, Inc., 15-1143 (D. Del.) Dec. 10, 2015 Hon. Richard G. Andrews Istodax® (romidepsin injection)
7,608,280
7,611,724
Aptalis Pharma US, Inc. v. Pharm. Sourcing Partners, Inc., 15-8637 (D.N.J.) Dec. 14, 2015 Hon. Mary L. Cooper Canasa® (mesalamine rectal suppositories)
7,541,384
8,217,083
8,436,051
Sandoz Inc. v. Eli Lilly & Co., IPR2016-00318 (PTAB) Dec. 14, 2015 N/A Alimta® (pemetrexed disodium injection) 7,772,209
Purdue Pharma L.P. v. Amneal Pharms. LLC, 15-1152 (D. Del.) Dec. 15, 2015 Hon. Sue L. Robinson OxyContin® (oxycodone extended-release tablets)
7,674,799
7,674,800
7,683,072
8,114,383
8,309,060
8,337,888
8,808,741
8,894,987
8,894,988
9,060,976
9,034,376
9,073,933
Helsinn Healthcare S.A. v. Dr. Reddy’s Labs., Ltd., 15-8662 (D.N.J.) Dec. 15, 2015 Hon. Mary L. Cooper Aloxi® (palonosetron hydrochloride for injection) 9,173,942
Helsinn Healthcare S.A. v. Teva Pharms. USA, Inc., 15-8663 (D.N.J.) Dec. 15, 2015 Hon. Mary L. Cooper Aloxi® (palonosetron hydrochloride for injection) 9,173,942
Purdue Pharma L.P. v. Mylan Pharms. Inc., 15-1155 (D. Del.) Dec. 16, 2015 Hon. Sue L. Robinson OxyContin® (oxycodone extended-release tablets) 9,073,933
Alcon Research Ltd. v. Watson Labs., Inc., 15-1159 (D. Del.) Dec. 16, 2015 Hon. Sue L. Robinson Pazeo® (olopatadine hydrochloride ophthalmic solution) 8,791,154
Sanofi-Aventis U.S. LLC v. Amylin Pharms., LLC, IPR2016-00348 (PTAB) Dec. 16, 2015 N/A Byetta® (exenatide injection) 7,297,761
Sanofi-Aventis U.S. LLC v. Amylin Pharms., LLC, IPR2016-00353 (PTAB) Dec. 16, 2015 N/A Byetta® (exenatide injection) 7,691,963
Sanofi-Aventis U.S. LLC v. Amylin Pharms., LLC, IPR2016-00354 (PTAB) Dec. 16, 2015 N/A Byetta® (exenatide injection) 8,445,647
Sanofi-Aventis U.S. LLC v. Amylin Pharms., LLC, IPR2016-00355 (PTAB) Dec. 16, 2015 N/A Byetta® (exenatide injection) 8,951,962
Shire Orphan Therapies LLC v. Sandoz Inc., 15-1161 (D. Del.) Dec. 17, 2015 Hon. Gregory M. Sleet Firazyr® (icatibant acetate) 5,648,333
Bayer Healthcare LLC v. Mylan Pharms. Inc., 15-1162 (D. Del.) Dec. 17, 2015 Hon. Leonard P. Stark Nexavar® (sorafenib tosylate tablets)
7,897,623
7,235,576
7,351,834
8,877,933
8,841,330
Cubist Pharms. LLC v. Sagent Pharms., Inc., 15-1164 (D. Del.) Dec. 17, 2015 Hon. Gregory M. Sleet Cubicin® (daptomycin for injection)
6,468,967
6,852,689
8,058,238
8,129,342
Purdue Pharma L.P. v. Mylan Pharms. Inc., 15-0232 (D. Del.) Dec. 17, 2015 Hon. Irene M. Keeley OxyContin® (oxycodone extended-release tablets) 9,073,933
Forest Labs., LLC v. Panacea Biotec, Ltd., 15-1171 (D. Del.) Dec. 18, 2015 Hon. Leonard P. Stark Namenda® XR (memantine hydrochloride extended-release tablets)
8,168,209
8,173,708
8,283,379
8,329,752
8,362,085
8,598,233
Lower Drug Prices for Consumers, LLC v. Forest Labs. Holdings, Ltd., IPR2016-00379 (PTAB) Dec. 22, 2015 N/A Bystolic® (nebivolol hydrochloride tablets) 6,545,040
Recro Gainesville LLC v. Actavis Labs. FL, Inc., 15-1196 (D. Del.) Dec. 23, 2015 Hon. Gregory M. Sleet Zohydro® ER (hydrocodone bitartrate extended-release capsules) 9,132,096
Sanofi v. Alkem Labs. Ltd., 15-1200 (D. Del.) Dec. 23, 2015 Hon. Richard G. Andrews Multaq® (dronedarone hydrochloride tablets) 9,107,900
Sanofi v. First Time US Generics LLC, 15-1205 (D. Del.) Dec. 23, 2015 Hon. Richard G. Andrews Multaq® (dronedarone hydrochloride tablets) 9,107,900
Sanofi v. Glenmark Pharms. Inc. USA, 15-1206 (D. Del.) Dec. 23, 2015 Hon. Richard G. Andrews Multaq® (dronedarone hydrochloride tablets) 9,107,900
Sanofi v. Sandoz Inc., 15-1207 (D. Del.) Dec. 23, 2015 Hon. Richard G. Andrews Multaq® (dronedarone hydrochloride tablets) 9,107,900
Sanofi v. Sun Pharma Global FZE, 15-1208 (D. Del.) Dec. 23, 2015 Hon. Richard G. Andrews Multaq® (dronedarone hydrochloride tablets) 9,107,900
Sanofi v. Watson Labs., Inc., 15-1209 (D. Del.) Dec. 23, 2015 Hon. Richard G. Andrews Multaq® (dronedarone hydrochloride tablets) 9,107,900
Otsuka Pharm. Co., Ltd. v. Ajanta Pharma Ltd., 15-8830 (D.N.J.) Dec. 23, 2015 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,089,567
Aptalis Pharma US, Inc. v. Delcor Asset Corp., 15-8919 (D.N.J.) Dec. 23, 2015 Hon. Mary L. Cooper Canasa® (mesalamine rectal suppositories)
7,541,384
8,217,083
8,436,051
Aptalis Pharma US, Inc. v. Delcor Asset Corp., 15-1210 (D. Del.) Dec. 27, 2015 Hon. Leonard P. Stark Canasa® (mesalamine rectal suppositories)
7,541,384
8,217,083
8,436,051
Lupin Ltd. v. iCeutica Pty Ltd., IPR2016-00397 (PTAB) Dec. 28, 2015 N/A Zorvolex® (diclofenac tablets) 8,999,387
Lupin Ltd. v. iCeutica Pty Ltd., IPR2016-00399 (PTAB) Dec. 28, 2015 N/A Zorvolex® (diclofenac tablets) 9,017,721
Cubist Pharms. LLC v. Actavis LLC, 15-1214 (D. Del.) Dec. 29, 2015 Hon. Gregory M. Sleet Cubicin® (daptomycin for injection)
6,468,967
6,852,689
8,058,238
8,129,342
Novartis Pharms. Corp. v. Actavis, Inc., 15-1219 (D. Del.) Dec. 30, 2015 Hon. Richard G. Andrews Jadenu® (deferasirox tablets) 6,465,504
Otsuka Pharm. Co., Ltd. v. Intas Pharms. Ltd., 15-8955 (D.N.J.) Dec. 30, 2015 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,089,567
Novartis Pharms. Corp. v. Actavis, Inc., 15-8978 (D.N.J.) Dec. 31, 2015 Hon. Jose L. Linares Jadenu® (deferasirox tablets) 6,465,504
Merz Pharms., LLC v. Taro Pharms. U.S.A., Inc., 15-10168 (S.D.N.Y.) Dec. 31, 2015 Hon. William H. Pauley, III Naftin® (naftifine hydrochloride gel) 9,161,914

Back to Top